Aethlon Medical, Inc.
AEMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,487 | -$1,761,858 | -$6,255 | -$1,755 |
| Dep. & Amort. | $153 | $82,637 | $84 | $84 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $72,442 | $72 | $90 |
| Change in WC | -$397 | -$180 | -$258 | -$500 |
| Other Non-Cash | $72 | -$107,978 | $4,684 | $71 |
| Operating Cash Flow | -$1,659 | -$1,714,937 | -$1,673 | -$2,011 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $2 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $2 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,744 | $0 | -$1,844 | $0 |
| Stock Repurch. | $0 | -$5 | $0 | -$7 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3 | -$5,352 | $4,203 | $0 |
| Financing Cash Flow | $3,741 | -$5,357 | $2,359 | -$7 |
| Forex Effect | $6 | -$15,496 | -$2 | -$14 |
| Net Chg. in Cash | $2,088 | -$1,735,790 | $686 | -$2,034 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,765 | $5,599,074 | $4,913 | $6,947 |
| End Cash | $5,853 | $3,863,284 | $5,599 | $4,913 |
| Free Cash Flow | -$1,659 | -$1,714,937 | -$1,670 | -$2,013 |